University of Michigan
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).
University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.
University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.
Top-decile sponsor footprint
University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,327 total, page 26 of 27
Comparison of Alveolar Macrophages in Individuals With COPD Versus Smokers With Normal Pulmonary Function
NCT00281190
Comparison of Alveolar Macrophages in Healthy Individuals Versus Individuals With COPD
NCT00281203
Growth Hormone as a Determinant of Weight Regulation
NCT00355784
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
NCT00281216
Ultrasound Evaluation of the Rotator Cable and Associated Structures.
NCT00743600
Exercise and Activity Guidance in Older Adults With Diabetes
NCT00344240
Non-cutting Laser Therapy in the Treatment of Acne
NCT00113425
The Effect of Efudex Treatment on Photoaged Skin
NCT00121511
Stepping Up to Health: Feedback to Promote Physical Activity in Diabetes
NCT00151021
Outcomes of Triaged Family Care in Advanced Cancer
NCT00709176
Integrated Microfluidic System for Oral Diagnostics
NCT00277745
Increasing Stroke Treatment Through Interventional Change Tactics Study
NCT00349479
Effective Care Management of Depressed Diabetes Patients (The Positive Steps Study)
NCT01106885
Effectiveness of Acupuncture in Relieving Pain Due to Fibromyalgia
NCT00142597
Pharmacokinetics of Mmf and Valganciclovir
NCT00189150
Memory for Flu Facts and Myths and Effects on Vaccine Intentions
NCT00296270
N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study)
NCT00374088
Pioglitazone in Hepatitis C
NCT00189163
The Effect of Laser Hair Removal on Permanent Hair Reduction
NCT00279643
Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania
NCT01654523
Identification of Sleep-Disordered Breathing in Children
NCT00233194
Refinement and Assessment of New Magnetic Resonance Imaging Technologies for Neurological Exams
NCT00739518
Pre and Post Arthrogram Ultrasound Images of Joints
NCT00724659
REACH Detroit Partnership Family Intervention
NCT00800410
Sleep Apnea Treatment After Stroke (SATS)
NCT00282815
Mechanisms of Skin Repair by Topical Estrogen
NCT00113100
Impact of Parathyroid Hormone (PTH) on Osseous Cavity
NCT00277706
Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans
NCT00189202
Significance of Biological Markers in Patients With Acute Lung Injury/Acute Respiratory Disease
NCT00217880
A Randomized Trial of GM-CSF in Patients With ALI/ARDS
NCT00201409
Molecular Mechanisms and Diagnosis of Mastocytosis
NCT00336076
A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris
NCT00113542
Nuclear Morphology of Breast Cells in Ductal Lavage
NCT00259597
Developing Violence Prevention Therapy for Substance Abusers
NCT00551863
Pain Management Techniques for Fibromyalgia
NCT00086060
Design and Feasibility of a Mediterranean Diet
NCT00120016
Effect of Soy Bread on Markers of Bone Metabolism and Cardiovascular Disease
NCT00366860
CellCept/Iron Study: The Iron Ion-Mycophenolate Mofetil Chelation Complex Interaction in Renal Allograft Recipients
NCT00227045
Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRI
NCT00721929
Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
NCT00189124
Preventive Health Behavior in Women
NCT00723996
Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the Hand
NCT00124254
Effects of Anticipation of Pain Relief on Brain Mechanisms
NCT00200876
Randomized Trial of a Quality Improvement Intervention to Decrease D2B Time in Primary PCI for AMI
NCT01625104
Fatty Acid Metabolism and Insulin Sensitivity After Exercise in Obesity
NCT01451957
Fatty Acid Metabolism and Insulin Sensitivity: the Role of Endurance Exercise
NCT00795860
Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis
NCT00189176
Infrared Non-Cutting Laser Therapy for Acne
NCT00110643
IRIS: Incontinence Research Intervention Study
NCT00125177
Ultrasound Elasticity Imaging of Venous Thrombi
NCT00726947
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 80 |
| Phase 3 | 25 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the University of Michigan pipeline
179 recruiting of 1,327 indexed (13% open); 971 completed (73%).
Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).
Top condition: Depression (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Michigan: open-pipeline peers nationwide
Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,327 trials (± recruiting share)
- Eli Lilly and Company · 1,341 trials · 9% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Wayne State University · 13% recruiting · 163 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Albany Medical College · 13% recruiting · 52 trials
- Taiho Oncology · 13% recruiting · 52 trials
Related
What to do with this University of Michigan page
1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.
- 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.